|Bid||8.82 x 4000|
|Ask||8.90 x 4000|
|Day's range||8.78 - 8.89|
|52-week range||3.14 - 9.20|
|Beta (5Y monthly)||1.62|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
NEW ORLEANS, September 10, 2021--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Kadmon Holdings, Inc. (NasdaqGS: KDMN) to Sanofi (NasdaqGS: SNY). Under the terms of the proposed transaction, shareholders of Kadmon will receive only $9.50 in cash for each share of Kadmon that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whet
NEW YORK, September 09, 2021--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Kadmon Holdings, Inc. (NASDAQ: KDMN) to Sanofi for $9.50 per share in cash is fair to Kadmon shareholders.
Virtual Investor Conferences in partnership with KCSA Strategic Communications and ATB Capital Markets today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The two-day program begins at 9:30 AM ET on Tuesday, June 29th.